Efficacy and safety of enzyme replacement therapy for MPS I with 100 I.U./Kg recombinant human a-L-iduronidase (ALDURAZYME)
Latest Information Update: 24 Aug 2021
At a glance
- Drugs Laronidase (Primary)
- Indications Mucopolysaccharidosis I
- Focus Therapeutic Use
- 20 Aug 2021 Status changed from active, no longer recruiting to completed.
- 08 May 2012 New source identified and integrated (Netherlands Trial Register NTR369).
- 08 May 2012 Status changed from completed to active, no longer recruiting as reported by Netherlands Trial Register record.